Related references
Note: Only part of the references are listed.Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study
Matthias Schiedel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondria! Function and Exhibit Inhibition of Proliferation in Cancer Cells
Sergio Valente et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Tumour-suppressive function of SIRT4 in human colorectal cancer
M. Miyo et al.
BRITISH JOURNAL OF CANCER (2015)
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease
Sigurd D. Suessmuth et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice
Myeong Jin Yoon et al.
CELL METABOLISM (2015)
The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine
Jean-Pierre Etchegaray et al.
NATURE CELL BIOLOGY (2015)
SIRTUIN 3 REGULATES Foxo3a-MEDIATED ANTIOXIDANT PATHWAY IN MICROGLIA
P. Rangarajan et al.
NEUROSCIENCE (2015)
SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
Chong Li et al.
ONCOTARGETS AND THERAPY (2015)
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
Tobias Rumpf et al.
NATURE COMMUNICATIONS (2015)
Crystallographic structure of a small molecule SIRT1 activator-enzyme complex
Han Dai et al.
NATURE COMMUNICATIONS (2015)
Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
Vinodkumar B. Pillai et al.
NATURE COMMUNICATIONS (2015)
Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1
Wen-Ying Lee et al.
ONCOTARGET (2015)
Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity
Joo-Man Park et al.
SCIENTIFIC REPORTS (2015)
The Deacetylase Sirtuin 1 Regulates Human Papillomavirus Replication by Modulating Histone Acetylation and Recruitment of DNA Damage Factors NBS1 and Rad51 to Viral Genomes
Erika S. Langsfeld et al.
PLOS PATHOGENS (2015)
The Sirtuin-2 Inhibitor AK7 Is Neuroprotective in Models of Parkinson's Disease but Not Amyotrophic Lateral Sclerosis and Cerebral Ischemia
Xiqun Chen et al.
PLOS ONE (2015)
Discovery of SIRT3 Inhibitors Using SAMDI Mass Spectrometry
Kaushal Patel et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Small-Molecule Allosteric Activators of Sirtuins
David A. Sinclair et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients
Remco S. Derr et al.
BMC CANCER (2014)
Sirtuin deacetylases: A new target for melanoma management
Melissa J. Wilking et al.
CELL CYCLE (2014)
Lysine Glutarylation Is a Protein Posttranslational Modification Regulated by SIRT5
Minjia Tan et al.
CELL METABOLISM (2014)
SIRT2: Tumour suppressor or tumour promoter in operable breast cancer?
Liane M. McGlynn et al.
EUROPEAN JOURNAL OF CANCER (2014)
Development of Pyrazolone and Isoxazol-5-one Cambinol Analogues as Sirtuin Inhibitors
Sumit S. Mahajan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of Potent and Selective Sirtuin 2 (SIRT2) Inhibitors Using a Fragment-Based Approach
Huaqing Cui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of Novel and Selective SIRT6 Inhibitors
Marco Daniele Parenti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Chroman-4-one- and Chromone-Based Sirtuin 2 Inhibitors with Antiproliferative Properties in Cancer Cells
Tina Seifert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Antitumor Effects of a Sirtuin Inhibitor, Tenovin-6, against Gastric Cancer Cells via Death Receptor 5 Up-Regulation
Sachiko Hirai et al.
PLOS ONE (2014)
Small molecule SIRT1 activators for the treatment of aging and age-related diseases
Basil P. Hubbard et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer
Weidong Lu et al.
TUMOR BIOLOGY (2014)
High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients
Xiaojing Chen et al.
SCIENTIFIC REPORTS (2014)
Sirt1 activation by resveratrol is substrate sequence-selective
Mahadevan Lakshminarasimhan et al.
AGING-US (2013)
The histone deacetylase SIRT2 stabilizes Myc oncoproteins
P. Y. Liu et al.
CELL DEATH AND DIFFERENTIATION (2013)
The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation
Lourdes Serrano et al.
GENES & DEVELOPMENT (2013)
A Nitric Oxide-dependent Cross-talk between Class I and III Histone Deacetylases Accelerates Skin Repair
Francesco Spallotta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Screen of Pseudopeptidic Inhibitors of Human Sirtuins 1-3: Two Lead Compounds with Antiproliferative Effects in Cancer Cells
Paolo Mellini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery of Thieno[3,2-4-d]pyrimidine-6-carboxamides as Potent Inhibitors of SIRT1, SIRT2, and SIRT3
Jeremy S. Disch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Antitumor Effect of SIRT1 Inhibition in Human HCC Tumor Models In Vitro and In Vivo
Simone Portmann et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Sirt1 Promotes Axonogenesis by Deacetylation of Akt and Inactivation of GSK3
Xiao-hong Li et al.
MOLECULAR NEUROBIOLOGY (2013)
Regulation of SIRT2 levels for human non-small cell lung cancer therapy
Ziming Li et al.
LUNG CANCER (2013)
Autophagy induced by the class III histone deacetylase Sirt1 prevents prion peptide neurotoxicity
Jae-Kyo Jeong et al.
NEUROBIOLOGY OF AGING (2013)
SIRT1 Expression Is Associated with the Chemotherapy Response and Prognosis of Patients with Advanced NSCLC
Tao Zhang et al.
PLOS ONE (2013)
Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism
Melanie Gertz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators
Basil P. Hubbard et al.
SCIENCE (2013)
Schistosoma mansoni Sirtuins: Characterization and Potential as Chemotherapeutic Targets
Julien Lancelot et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
The lifespan extension effects of resveratrol are conserved in the honey bee and may be driven by a mechanism related to caloric restriction
Brenda Rascon et al.
AGING-US (2012)
SIRT2 activity is required for the survival of C6 glioma cells
Xin He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Sirtuin activators and inhibitors
Jose M. Villalba et al.
BIOFACTORS (2012)
Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis
Hongfeng Yuan et al.
BLOOD (2012)
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Sung-Jun Park et al.
CELL (2012)
A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53
Qi Zhang et al.
EMBO MOLECULAR MEDICINE (2012)
High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells
Tomohiro Kozako et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Benzodeazaoxaflavins as Sirtuin Inhibitors with Antiproliferative Properties in Cancer Stem Cells
Dante Rotili et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Discovery of Salermide-Related Sirtuin Inhibitors: Binding Mode Studies and Antiproliferative Effects in Cancer Cells Including Cancer Stem Cells
Dante Rotili et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Synthesis and Evaluation of Substituted Chroman-4-one and Chromone Derivatives as Sirtuin 2-Selective Inhibitors
Maria Friden-Saxin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
SIRT1 Protects against α-Synuclein Aggregation by Activating Molecular Chaperones
Gizem Donmez et al.
JOURNAL OF NEUROSCIENCE (2012)
Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway
Hyunkyung Jeong et al.
NATURE MEDICINE (2012)
Peptides and Pseudopeptides as SIRT6 Deacetylation Inhibitors
Piia Kokkonen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington's Disease Mouse Models
Vanita Chopra et al.
CELL REPORTS (2012)
Sirtuins and disease: the road ahead
Vincenzo Carafa et al.
FRONTIERS IN PHARMACOLOGY (2012)
A Brain-Permeable Small Molecule Reduces Neuronal Cholesterol by Inhibiting Activity of Sirtuin 2 Deacetylase
David M. Taylor et al.
ACS CHEMICAL BIOLOGY (2011)
Simplification of the tetracyclic SIRT1-selective inhibitor MC2141: Coumarin- and pyrimidine-based SIRT1/2 inhibitors with different selectivity profile
Dante Rotili et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Structure-Based Design of Pseudopeptidic Inhibitors for SIRT1 and SIRT-2
Tero Huhtiniemi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Succinate Dehydrogenase Is a Direct Target of Sirtuin 3 Deacetylase Activity
Lydia W. S. Finley et al.
PLOS ONE (2011)
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
Jintang Du et al.
SCIENCE (2011)
SRT1720 improves survival and healthspan of obese mice
Robin K. Minor et al.
SCIENTIFIC REPORTS (2011)
SIRT1 Promotes N-Myc Oncogenesis through a Positive Feedback Loop Involving the Effects of MKP3 and ERK on N-Myc Protein Stability
Glenn M. Marshall et al.
PLOS GENETICS (2011)
Nε-Modified lysine containing inhibitors for SIRT1 and SIRT2
Tero Huhtiniemi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Sirt3 Mediates Reduction of Oxidative Damage and Prevention of Age-Related Hearing Loss under Caloric Restriction
Shinichi Someya et al.
CELL (2010)
Identification of Tri- and Tetracyclic Pyrimidinediones as Sirtuin Inhibitors
Dante Rotili et al.
CHEMMEDCHEM (2010)
SIRT2-mediated protein deacetylation: An emerging key regulator in brain physiology and pathology
Kai Harting et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2010)
SIRT1 Activation by Small Molecules KINETIC AND BIOPHYSICAL EVIDENCE FOR DIRECT INTERACTION OF ENZYME AND ACTIVATOR
Han Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
Michelle Pacholec et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells
Ke Long Jin et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2010)
Characterization of Sirtuin Inhibitors in Nematodes Expressing a Muscular Dystrophy Protein Reveals Muscle Cell and Behavioral Protection by Specific Sirtinol Analogues
Matthieu Y. Pasco et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Sirt3-Mediated Deacetylation of Evolutionarily Conserved Lysine 122 Regulates MnSOD Activity in Response to Stress
Randa Tao et al.
MOLECULAR CELL (2010)
Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators
Jean E. Bemis et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine
Takayoshi Suzuki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
Chu-Xia Deng
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2009)
Nε-Thioacetyl-Lysine-Containing Tri-, Tetra-, and Pentapeptides as SIRT1 and SIRT2 Inhibitors
Paivi H. Kiviranta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Novel Cambinol Analogs as Sirtuin Inhibitors: Synthesis, Biological Evaluation, and Rationalization of Activity
Federico Medda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Study of 1,4-Dihydropyridine Structural Scaffold: Discovery of Novel Sirtuin Activators and Inhibitors
Antonello Mai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Inhibition of Human Sirtuins by in Situ Generation of an Acetylated Lysine-ADP-Ribose Conjugate
Tomomi Asaba et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
E. Lara et al.
ONCOGENE (2009)
A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells
Keitaro Kojima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator
Sonia Lain et al.
CANCER CELL (2008)
Substituting N-epsilon-thioacetyl-lysine for N-epsilon-acetyl-lysine in peptide substrates as a general approach to inhibiting human NAD(+)-dependent protein deacetylases
David G. Fatkins et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2008)
Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode
Robert C. Neugebauer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases
Brian C. Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide
Brian C. Smith et al.
BIOCHEMISTRY (2007)
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Jill C. Milne et al.
NATURE (2007)
SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation
Enxuan Jing et al.
CELL METABOLISM (2007)
Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease
Tiago Fleming Outeiro et al.
SCIENCE (2007)
SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress
T. Inoue et al.
ONCOGENE (2007)
SIRT1 interacts with p73 and suppresses p73-dependent transcriptional activity
Jin Ming Dai et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
N-epsilon-methanesulfonyl-lysine as a non-hydrolyzable functional surrogate for N-epsilon-acetyl-lysine
Nuttara Jamonnak et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2007)
Resveratrol improves health and survival of mice on a high-calorie diet
Joseph A. Baur et al.
NATURE (2006)
Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction
Weiping Qin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Nε-thioacetyl-lysine:: A multi-facet functional probe for enzymatic protein lysine Nε-deacetylation
David G. Fatkins et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes
B Heltweg et al.
CANCER RESEARCH (2006)
Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation
Kevin Pruitt et al.
PLOS GENETICS (2006)
Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate
DR Valenzano et al.
CURRENT BIOLOGY (2006)
Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage
JM Solomon et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1
AD Napper et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Substrate-specific activation of sirtuins by resveratrol
M Kaeberlein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
SIRT1 regulates HIV transcription via Tat deacetylation
S Pagans et al.
PLOS BIOLOGY (2005)
Mammalian SIRT1 represses forkhead transcription factors
MC Motta et al.
CELL (2004)
Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration
T Araki et al.
SCIENCE (2004)
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
JG Wood et al.
NATURE (2004)
Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases
MT Borra et al.
BIOCHEMISTRY (2004)
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
HY Cohen et al.
SCIENCE (2004)
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
KT Howitz et al.
NATURE (2003)
Identification of a small molecule inhibitor of Sir2p
A Bedalov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening
CM Grozinger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Negative control of p53 by Sir2α promotes cell survival under stress
JY Luo et al.
CELL (2001)
hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase
H Vaziri et al.
CELL (2001)
Share Paper
